A real-world study from Brazil found the TAK-003 dengue vaccine provided strong protection against symptomatic disease and hospitalization, offering new evidence to inform vaccination strategies during large dengue outbreaks.
Julio Croda, MD, PhD
Advertisement
Julio Croda, MD, PhD, is a study investigator and researcher at the Oswaldo Cruz Foundation, and professor at the Federal University of Mato Grosso do Sul and the Yale School of Public Health
Articles by Julio Croda, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Infection Control Today
1
The Price of Late Detection: What a CDC Model Reveals About the 2026 Ebola Bundibugyo Outbreak
2
Breath Tests in Infection Control: The Hype and the Hurdles
3
How Real-World Data Is Shaping the Future of Dengue Vaccination
4